Pinsent Masons launches parallel trade monitoring platform for life sciences sector

09 Mar 2022 | 11:01 am | 1 min. read

Multinational law firm Pinsent Masons launches innovative online tool to help life sciences organisations grappling with parallel trade management.

Parallens enables manufacturers and brand owners across the life sciences sector to track parallel trade notices, as well as guiding them on when and how objections can be raised - facilitating timely responses. The platform seeks to turn the data from notices into actionable intelligence, allowing organisations to identify the products being targeted by parallel traders and ultimately where organisations may face supply chain shortages.

Parallel trade is popular across the life sciences sectors, with parallel traders buying goods placed on the market in one country (often where prices are lower) and then selling them into another at a higher price. There are a number of requirements that parallel traders must meet in order to legally import products from one EU country to another, or into the UK, including repackaging products to meet local regulatory requirements and notifying rightsholders of those product changes.

Improved monitoring and increased visibility of parallel trade is more important than ever for manufacturers as supply chains for medicines have been significantly impacted by the COVID-19 pandemic, with disruption in the manufacture of goods and spikes in demand resulting in increased movement of goods across Europe.

Leading on the development of Parallens, brand protection and parallel trade expert in the pharmaceuticals market Emily Swithenbank commented:

“Working with clients across the life sciences sector we know how time consuming and difficult parallel trade can be to manage and wanted to develop a solution to help simplify this. Poor management of parallel goods can be costly and have far-reaching brand ramifications – particularly where medicines are concerned. Also, at a time of huge disruption to global supply chains, it is vital for organisations to understand where future issues may arise, giving them time to mitigate against issues such as shortages of products.”

Adding to this, life sciences partner Marc Holtorf said:

“Parallel trade is something that will continue to grow, and it will only become more important for life sciences organisations to have measures in place to help manage this. For example, Germany, Europe's largest pharmaceutical market, is increasingly becoming a parallel trade export country as result of numerous legislative steps put in place to regulate prices for medicinal products. Organisations need to ensure they are getting this right.”

Pinsent Masons will be discussing this further during their webinar on 10 March, exploring the IP, competition and Brexit related considerations surrounding the free movement of goods between the UK and EU

Key Contacts

Marc L. Holtorf

Marc L. Holtorf

Rechtsanwalt, Partner, Head of German Life Sciences

View Profile

Latest press releases

Show me all press releases

Pinsent Masons hires real estate partner in the Middle East

Multinational law firm Pinsent Masons has hired real estate partner, Louisa Lynch, in Dubai.

Pinsent Masons appoints Andy Wright as new pensions partner in Leeds

Multinational law firm Pinsent Masons has hired pensions partner Andy Wright into its Leeds office, taking the size of its pension team to 64.

Pinsent Masons advises jewellery brand Monica Vinader on Bridgepoint Development Capital’s strategic investment

Multinational law firm Pinsent Masons has advised renowned affordable luxury jewellery brand Monica Vinader on the latest strategic investment from Bridgepoint Development Capital IV, a fund focused on investing in mid-market growth businesses.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons hires investor-state arbitration specialist in London

Global law firm Pinsent Masons has hired partner Sylvia Tonova to the firm’s International Arbitration Practice.

Pinsent Masons appoints life sciences patent expert in its London office

Multinational law firm Pinsent Masons has hired European and UK life sciences partner Kristina Cornish into its London office.

Pinsent Masons hires corporate partner in Melbourne

Multinational law firm Pinsent Masons has strengthened its corporate team in Australia with the recruitment of partner Andrew Fisken.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.